You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Camber Capital Management | 0 | 2,500,000 | 0 | 2,500,000 | Camber% | |
Stephen DuBois Not applicable | 0 | 2,500,000 | 0 | 2,500,000 | Stephen% |
Follow Stephen R. Dubois's Camber Capital Management
Page 1 of 6 – SEC Filing
COMMISSION
1934
Inc.
Issuer)
share
Securities)
Number)
Which Requires Filing of this Statement)
appropriate box to designate the rule pursuant to which this
Schedule is filed:
13d-1(b)
Rule
13d-1(c)
13d-1(d)
this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover
page.
required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise
subject to the liabilities of that section of the Act but shall be
subject to all other provisions of the Act (however, see the
Notes).
information contained in this form are not
required to respond unless the form displays a currently valid OMB
control number.
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 2 of 6 – SEC Filing
CUSIP No. 00163U106
6
1. Names of Reporting Persons. Camber Capital Management LLC 42-1693587 | |
2. Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐ | |
3. SEC Use Only | |
4. Citizenship or Place of Organization Massachusetts | |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. Sole Voting Power 0 shares |
6. Shared Voting Power 2,500,000 shares | |
7. Sole Dispositive Power 0 shares | |
8. Shared Dispositive Power 2,500,000 shares | |
9. Aggregate Amount Beneficially Owned by Each Reporting Person Camber Capital Management LLC – 2,500,000 shares | |
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares ☐ | |
11. Percent of Class Represented by Amount in Row (9) Camber Capital Management LLC – 7.13% | |
12. Type of Reporting Person Camber Capital Management LLC – 00 (Limited Liability Company) |
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 3 of 6 – SEC Filing
00163U106
6
1. Names of Reporting Persons. Stephen DuBois Not applicable | |
2. Check the Appropriate Box if a Member of a Group (a) ☐ (b) ☐ | |
3. SEC Use Only | |
4. Citizenship or Place of Organization Stephen DuBois – United States | |
Number of Shares Beneficially Owned by Each Reporting Person With: | 5. Sole Voting Power 0 shares |
6. Shared Voting Power 2,500,000 shares | |
7. Sole Dispositive Power 0 shares | |
8. Shared Dispositive Power 2,500,000 shares | |
9. Aggregate Amount Beneficially Owned by Each Reporting Person Stephen DuBois – 2,500,000 shares | |
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares ☐ | |
11. Percent of Class Represented by Amount in Row (9) Stephen DuBois – 7.13% | |
12. Type of Reporting Person Stephen DuBois – IN |
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 4 of 6 – SEC Filing
CUSIP No. 00163U106
6
|
Issuer:
Pharmaceuticals, Inc.
Issuer’s Principal Executive Offices:
Winter Street, Waltham, MA 02451
Filing:
Management LLC
DuBois
Principal Business Office, or if None, Residence:
Management LLC
DuBois
Avenue
2101
02199
Citizenship:
Management LLC –
Massachusetts
DuBois – United
States
of Securities:
value $0.01 per share
Number:
SS.240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON
FILING IS A:
| (a) | [_] | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). |
| (b) | [_] | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | [_] | Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). |
| (d) | [_] | Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | [_] | An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(E); |
| (f) | [_] | An employee benefit plan or endowment fund in accordance with ss.240.13d-1(b)(1)(ii)(F); |
| (g) | [_] | A parent holding company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G); |
| (h) | [_] | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) | [_] | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
| (j) | [_] | Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). |
following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item
1.
beneficially owned: Camber Capital Management LLC –
2,500,000
shares
– 2,500,000
shares
class: Camber Capital Management LLC –
7.13%
– 7.13%
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 5 of 6 – SEC Filing
CUSIP No. 00163U106
6
|
shares as to which such person has:
vote or to direct the vote
Management LLC – 0 shares
– 0 shares
to vote or to direct the vote
Management LLC – 2,500,000
shares
– 2,500,000
shares
dispose or to direct the disposition of
Management LLC – 0 shares
– 0 shares
to dispose or to direct the disposition of
Management LLC – 2,500,000
shares
– 2,500,000
shares
CLASS.
is being filed to report the fact that as of the date hereof the
reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [
].
Dissolution of a group requires a response to this
item.
BEHALF OF ANOTHER PERSON.
is known to have the right to receive or the power to direct the
receipt of dividends from, or the proceeds from the sale of, such
securities, a statement to that effect should be included in
response to this item and, if such interest relates to more than
five percent of the class, such person should be identified. A
listing of the shareholders of an investment company registered
under the Investment Company Act of 1940 or the beneficiaries of
employee benefit plan, pension fund or endowment fund is not
required.
THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE
PARENT HOLDING COMPANY.
company or Control person has filed this schedule, pursuant to Rule
13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an
exhibit stating the identity and the Item 3 classification of the
relevant subsidiary. If a parent holding company or control person
has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d),
attach an exhibit stating the identification of the relevant
subsidiary.
MEMBERS OF THE GROUP.
filed this schedule pursuant to ss.240.13d-1(b)(1)(ii)(J), so
indicate under Item 3(j) and attach an exhibit stating the identity
and Item 3 classification of each member of the group. If a group
has filed this schedule pursuant to ss.240.13d-1(c) or
ss.240.13d-1(d), attach an exhibit stating the identity of each
member of the group.
GROUP.
dissolution of a group may be furnished as an exhibit stating the
date of the dissolution and that all further filings with respect
to transactions in the security reported on will be filed, if
required, by members of the group, in their individual capacity.
See Item 5.
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Follow Amag Pharmaceuticals Inc. (NASDAQ:AMAG)
Page 6 of 6 – SEC Filing
CUSIP No. 00163U106
6
|
certification shall be included if the statement is filed pursuant
to S.240.13d-1(c):
certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any
transaction having such purpose or effect.
inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
MANAGEMENT LLC
George
George
Officer
DUBOIS
DuBois
individually
statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the
statement is signed on behalf of a person by his authorized
representative other than an executive officer or general partner
of the filing person, evidence of the representative’s authority to
sign on behalf of such person shall be filed with the statement,
provided, however, that a power of attorney for this purpose which
is already on file with the Commission may be incorporated by
reference. The name and any title of each person who signs the
statement shall be typed or printed beneath his
signature.